Literature DB >> 2770183

Inhibition of human adrenal androgen secretion by ketoconazole.

M M Weber1, P Luppa, D Engelhardt.   

Abstract

The effect of ketoconazole on adrenal androgen secretion was examined in 15 patients with elevated serum androgens. In a dose of 600 mg per day orally ketoconazole inhibited the biosynthesis of all measured androgens. The mean reduction in serum levels of dehydroepiandrosterone sulfate was 32%, of dehydroepiandrosterone 54%, of androstenedione 52%, and of testosterone 43%; mean serum levels of cortisol only fell by 19%. The reduction in serum androgen levels was first significant 24 h after beginning of treatment and persisted as long as the drug was administered. We conclude that ketoconazole inhibits adrenal androgen biosynthesis more pronouncedly than cortisol biosynthesis more pronouncedly than cortisol biosynthesis. This might be of clinical benefit in the treatment of hirsutism and other states of androgen hypersecretion.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2770183     DOI: 10.1007/BF01721288

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  30 in total

1.  Ketoconazole reverses hyperandrogenism in a patient with insulin resistance and acanthosis nigricans.

Authors:  G M Pepper; L Poretsky; J L Gabrilove; M M Ariton
Journal:  J Clin Endocrinol Metab       Date:  1987-11       Impact factor: 5.958

2.  Hormonal and clinical effects of ketoconazole in hirsute women.

Authors:  H Martikainen; J Heikkinen; A Ruokonen; A Kauppila
Journal:  J Clin Endocrinol Metab       Date:  1988-05       Impact factor: 5.958

3.  Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis.

Authors:  T Schürmeyer; E Nieschlag
Journal:  Acta Endocrinol (Copenh)       Date:  1984-02

4.  Gonadotropin-independent precocious puberty ("testotoxicosis"): influence of maturational status on response to ketoconazole.

Authors:  F J Holland; S E Kirsch; R Selby
Journal:  J Clin Endocrinol Metab       Date:  1987-02       Impact factor: 5.958

5.  Ketoconazole blocks testosterone synthesis.

Authors:  A Pont; P L Williams; S Azhar; R E Reitz; C Bochra; E R Smith; D A Stevens
Journal:  Arch Intern Med       Date:  1982-11

6.  Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer.

Authors:  G Williams; D J Kerle; H Ware; A Doble; H Dunlop; C Smith; J Allen; T Yeo; S R Bloom
Journal:  Br J Urol       Date:  1986-02

Review 7.  Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use.

Authors:  J H Van Tyle
Journal:  Pharmacotherapy       Date:  1984 Nov-Dec       Impact factor: 4.705

8.  Site of action of low dose ketoconazole on androgen biosynthesis in men.

Authors:  R J Santen; H Van den Bossche; J Symoens; J Brugmans; R DeCoster
Journal:  J Clin Endocrinol Metab       Date:  1983-10       Impact factor: 5.958

9.  Effects of high dose ketoconazole therapy on the main plasma testicular and adrenal steroids in previously untreated prostatic cancer patients.

Authors:  R De Coster; I Caers; M C Coene; W Amery; D Beerens; C Haelterman
Journal:  Clin Endocrinol (Oxf)       Date:  1986-06       Impact factor: 3.478

10.  High-dose ketoconazole therapy in patients with metastatic prostate cancer.

Authors:  E Tapazoglou; M G Subramanian; M Al-Sarraf; C Kresge; D A Decker
Journal:  Am J Clin Oncol       Date:  1986-10       Impact factor: 2.339

View more
  4 in total

Review 1.  Steroid biosynthesis inhibitors in Cushing's syndrome.

Authors:  D Engelhardt
Journal:  Clin Investig       Date:  1994-07

2.  Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis.

Authors:  M M Weber; J Lang; F Abedinpour; K Zeilberger; B Adelmann; D Engelhardt
Journal:  Clin Investig       Date:  1993-11

3.  Vitamin D3 May Ameliorate the Ketoconazole Induced Adrenal Injury: Histological and Immunohistochemical Studies on Albino Rats.

Authors:  Mahmoud Salah Khalil
Journal:  Acta Histochem Cytochem       Date:  2015-08-20       Impact factor: 1.938

4.  Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing's syndrome.

Authors:  Eliza B Geer; Roberto Salvatori; Atanaska Elenkova; Maria Fleseriu; Rosario Pivonello; Przemyslaw Witek; Richard A Feelders; Marie Bex; Stina W Borresen; Soraya Puglisi; Beverly M K Biller; Fredric Cohen; Francesca Pecori Giraldi
Journal:  Pituitary       Date:  2020-11-20       Impact factor: 4.107

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.